Cargando…
Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783564/ https://www.ncbi.nlm.nih.gov/pubmed/33426402 http://dx.doi.org/10.1016/j.ekir.2020.10.012 |
| _version_ | 1783632139919556608 |
|---|---|
| author | Ainley, Louise Law, Steven Heptinstall, Lauren Rodriguez-Justo, Manuel Thomson, Kirsty Pepper, Ruth J. |
| author_facet | Ainley, Louise Law, Steven Heptinstall, Lauren Rodriguez-Justo, Manuel Thomson, Kirsty Pepper, Ruth J. |
| author_sort | Ainley, Louise |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7783564 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77835642021-01-08 Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation Ainley, Louise Law, Steven Heptinstall, Lauren Rodriguez-Justo, Manuel Thomson, Kirsty Pepper, Ruth J. Kidney Int Rep Nephrology Rounds Elsevier 2020-10-17 /pmc/articles/PMC7783564/ /pubmed/33426402 http://dx.doi.org/10.1016/j.ekir.2020.10.012 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Nephrology Rounds Ainley, Louise Law, Steven Heptinstall, Lauren Rodriguez-Justo, Manuel Thomson, Kirsty Pepper, Ruth J. Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation |
| title | Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation |
| title_full | Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation |
| title_fullStr | Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation |
| title_full_unstemmed | Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation |
| title_short | Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation |
| title_sort | treatment of concurrent minimal change disease and epstein barr virus–driven post-transplant lymphoproliferative disorder with rituximab following hematopoietic stem cell transplantation |
| topic | Nephrology Rounds |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783564/ https://www.ncbi.nlm.nih.gov/pubmed/33426402 http://dx.doi.org/10.1016/j.ekir.2020.10.012 |
| work_keys_str_mv | AT ainleylouise treatmentofconcurrentminimalchangediseaseandepsteinbarrvirusdrivenposttransplantlymphoproliferativedisorderwithrituximabfollowinghematopoieticstemcelltransplantation AT lawsteven treatmentofconcurrentminimalchangediseaseandepsteinbarrvirusdrivenposttransplantlymphoproliferativedisorderwithrituximabfollowinghematopoieticstemcelltransplantation AT heptinstalllauren treatmentofconcurrentminimalchangediseaseandepsteinbarrvirusdrivenposttransplantlymphoproliferativedisorderwithrituximabfollowinghematopoieticstemcelltransplantation AT rodriguezjustomanuel treatmentofconcurrentminimalchangediseaseandepsteinbarrvirusdrivenposttransplantlymphoproliferativedisorderwithrituximabfollowinghematopoieticstemcelltransplantation AT thomsonkirsty treatmentofconcurrentminimalchangediseaseandepsteinbarrvirusdrivenposttransplantlymphoproliferativedisorderwithrituximabfollowinghematopoieticstemcelltransplantation AT pepperruthj treatmentofconcurrentminimalchangediseaseandepsteinbarrvirusdrivenposttransplantlymphoproliferativedisorderwithrituximabfollowinghematopoieticstemcelltransplantation |